Active surveillance of early prostate cancer: rationale, initial results and future developments

Prostate Cancer and Prostatic Diseases
C Parker

Abstract

Active surveillance is a new strategy that aims to individualise therapy by selecting only those men with significant cancers for curative therapy based on early evidence of disease progression. Active surveillance must be distinguished from watchful waiting, which for decades has described a policy of observation with the use of palliative treatment for symptomatic progression. The rationale for active surveillance is discussed, based on our knowledge of the natural history of PSA-detected early prostate cancer. The initial results of active surveillance have demonstrated its feasibility. Ongoing studies seek to optimise the active surveillance protocol, and to determine the long-term outcomes. Looking ahead, dietary intervention in men on active surveillance could become an important new paradigm for prostate cancer management.

References

Jan 1, 1993·European Urology·H P SchmidT A Stamey
Jan 27, 1994·The New England Journal of Medicine·G W ChodakJ Warner
Sep 28, 1998·JAMA : the Journal of the American Medical Association·P C AlbertsenM J Barry
Mar 3, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C C Parker, D P Dearnaley
Oct 6, 2000·International Journal of Radiation Oncology, Biology, Physics·H M SandlerJ M Taylor
Jun 8, 2001·International Journal of Radiation Oncology, Biology, Physics·R ChooG Hruby
Feb 8, 2002·The Journal of Urology·H Ballentine CarterJonathan I Epstein
Jul 4, 2002·Journal of the National Cancer Institute·Ruth EtzioniEric J Feuer
Sep 13, 2002·The New England Journal of Medicine·Gunnar SteineckUNKNOWN Scandinavian Prostatic Cancer Group Study Number 4
Nov 2, 2002·BJU International·P W Nicholson, S J Harland
Apr 24, 2003·Health Technology Assessment : HTA·J DonovanUNKNOWN ProtecT Study Group

❮ Previous
Next ❯

Citations

Jun 22, 2006·Der Urologe. Ausg. A·M SchenckM Stuschke
Apr 2, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ramachandran VenkitaramanChristopher C Parker
Jul 22, 2010·Expert Review of Anticancer Therapy·Heidi A van VugtMonique J Roobol
Nov 6, 2012·Radiologic Clinics of North America·Dow-Mu Koh, Aslam Sohaib
Jun 10, 2008·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·J-M Hannoun-LeviJ Thariat
Nov 27, 2007·Cancer Genetics and Cytogenetics·Nicola Brookman-AmissahMark R Feneley
May 20, 2006·Annales D'urologie·P Perrin
Mar 1, 2007·American Journal of Men's Health·Donald E Bailey, Meredith Wallace
Sep 28, 2006·British Journal of Cancer·C MetcalfeJ L Donovan
Dec 26, 2019·The Tohoku Journal of Experimental Medicine·Kenichi KomatsuKazuhiko Kotani
Aug 1, 2012·Science China. Mathematics·Hong Li, Constantine Gatsonis
Aug 19, 2016·JBI Database of Systematic Reviews and Implementation Reports·Leslie RittenmeyerEllen Moore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.